Sec. 20. Requirements; notice.
169 words·~1 min read·
/il/chapter-410/act-416/20A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Sec. 20. Requirements; notice.
(a)The program:
(1)must collaborate with physicians, health care providers, and clinical trial
sponsors to notify a prospective subject about the program when:
(A)the prospective subject consents to a clinical trial; or
(B)funding is available to provide the program for the clinical trial in which the
prospective subject participates;
(2)must reimburse subjects based on financial need, which may include reimbursement to
subjects whose income is at or below 700% of the federal poverty level;
(3)must provide reimbursement for ancillary costs, including costs described under
Section 15, to eliminate the financial barriers to enrollment in a clinical trial;
(4)may provide reimbursement for reasonable ancillary costs, including costs described
under Section 15, to one family member, friend, or other person who attends a clinical trial to support a subject; and
(5)must comply with applicable federal and State laws.
(b)The independent third-party organization administering the program shall provide written notice to prospective subjects of the requirements described under subsection (a).